About
Cancer Treatment Matching
Areas of Focus
Categories
DiagnosticsNJ, NY, PA
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
7
As Collaborator
4
Total Enrollment
13,917
By Phase
PHASE2: 5NA: 2PHASE3: 1
By Status
RECRUITING: 3COMPLETED: 3UNKNOWN: 2TERMINATED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
Today
Hover over trial bars to see details
Recent Trials
NCT06481163Lead Sponsor
Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).
PHASE2Recruiting
120 participants
Started: Jul 9, 2024 · Completed: Dec 31, 2026
NCT06279260Collaborator
National Robotics-Assisted Radical Prostatectomy Database
N/ARecruiting
10,000 participants
Started: Jul 1, 2024 · Completed: Dec 31, 2050
NCT05788081Collaborator
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
PHASE2Active, not recruiting
40 participants
Started: Aug 31, 2023 · Completed: Jun 1, 2027
NCT03793257Collaborator
The EXCEL Registry of Patients Requiring ECMO
N/ARecruiting
3,000 participants
Started: Feb 1, 2019 · Completed: Dec 31, 2027
NCT03333278Collaborator
The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial
PHASE2Completed
216 participants
Started: May 2, 2018 · Completed: Oct 6, 2019
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...